Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|22|44|6682-6693
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.22, Iss.44, 2017-01, pp. : 6682-6693
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Current Perspectives on the Therapeutic Utility of VR1 Antagonists
Current Medicinal Chemistry, Vol. 11, Iss. 24, 2004-12 ,pp. :
Therapeutic prospects for epigenetic modulation
Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 6, 2011-06 ,pp. :